These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 20973771)

  • 21. Pilot study using teledermatology to manage high-need patients with psoriasis.
    Frühauf J; Schwantzer G; Ambros-Rudolph CM; Weger W; Ahlgrimm-Siess V; Salmhofer W; Hofmann-Wellenhof R
    Arch Dermatol; 2010 Feb; 146(2):200-1. PubMed ID: 20157037
    [No Abstract]   [Full Text] [Related]  

  • 22. Treatment with 311-nm ultraviolet B accelerates and improves the clearance of psoriatic lesions in patients treated with etanercept.
    Wolf P; Hofer A; Legat FJ; Bretterklieber A; Weger W; Salmhofer W; Kerl H
    Br J Dermatol; 2009 Jan; 160(1):186-9. PubMed ID: 19067710
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of etanercept in children.
    Wargula JC; Lovell DJ
    Bull Rheum Dis; 2000; 49(12):1-4. PubMed ID: 11314579
    [No Abstract]   [Full Text] [Related]  

  • 24. Utilization of narrow-band ultraviolet light B therapy and etanercept for the treatment of psoriasis (UNITE): efficacy, safety, and patient-reported outcomes.
    Kircik L; Bagel J; Korman N; Menter A; Elmets CA; Koo J; Yang YC; Chiou CF; Dann F; Stevens SR;
    J Drugs Dermatol; 2008 Mar; 7(3):245-53. PubMed ID: 18380206
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The treatment of psoriasis with etanercept.
    Strober BE
    Semin Cutan Med Surg; 2005 Mar; 24(1):28-36. PubMed ID: 15900796
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of pemphigus vulgaris in a patient with psoriasis treated with etanercept.
    Daulat S; Detweiler JG; Pandya AG
    J Eur Acad Dermatol Venereol; 2009 Apr; 23(4):483-4. PubMed ID: 18793242
    [No Abstract]   [Full Text] [Related]  

  • 27. Is etanercept safe for treating plaque psoriasis in a patient with chronic hepatitis C virus infection?
    Gandhi RK; Pickup T; Sheth PB
    Arch Dermatol; 2010 Oct; 146(10):1151-2. PubMed ID: 20956650
    [No Abstract]   [Full Text] [Related]  

  • 28. Treatment of erythrodermic psoriasis with etanercept.
    Esposito M; Mazzotta A; de Felice C; Papoutsaki M; Chimenti S
    Br J Dermatol; 2006 Jul; 155(1):156-9. PubMed ID: 16792768
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nicolau syndrome following etanercept administration.
    Guarneri C; Polimeni G
    Am J Clin Dermatol; 2010; 11 Suppl 1():51-2. PubMed ID: 20586511
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The combination of etanercept and methotrexate increases the effectiveness of treatment in active psoriasis despite inadequate effect of methotrexate therapy.
    Zachariae C; Mørk NJ; Reunala T; Lorentzen H; Falk E; Karvonen SL; Johannesson A; Claréus B; Skov L; Mørk G; Walker S; Qvitzau S
    Acta Derm Venereol; 2008; 88(5):495-501. PubMed ID: 18779890
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Long-term safety and efficacy of etanercept in the treatment of psoriasis].
    Zaragoza V; Pérez A; Sánchez JL; Oliver V; Martínez L; Alegre V
    Actas Dermosifiliogr; 2010; 101(1):47-53. PubMed ID: 20109392
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Once-weekly administration of high-dosage Etanercept in patients with plaque psoriasis: results of a pilot experience (power study).
    Cassano N; Loconsole F; Galluccio A; Miracapillo A; Pezza M; Vena GA
    Int J Immunopathol Pharmacol; 2006; 19(1):225-9. PubMed ID: 16569361
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A placebo-controlled double blind trial of etanercept for the cancer anorexia/weight loss syndrome: results from N00C1 from the North Central Cancer Treatment Group.
    Jatoi A; Dakhil SR; Nguyen PL; Sloan JA; Kugler JW; Rowland KM; Soori GS; Wender DB; Fitch TR; Novotny PJ; Loprinzi CL
    Cancer; 2007 Sep; 110(6):1396-403. PubMed ID: 17674351
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Etanercept combined with methotrexate for high-need psoriasis.
    Driessen RJ; van de Kerkhof PC; de Jong EM
    Br J Dermatol; 2008 Aug; 159(2):460-3. PubMed ID: 18547310
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Resident Rounds. Part III B: tumor necrosis factor-α antagonists and alopecia areata: a class-wide adverse effect.
    Griffith JL; Ledet JJ; Elewski BE
    J Drugs Dermatol; 2013 Jun; 12(6):713-4. PubMed ID: 23839195
    [No Abstract]   [Full Text] [Related]  

  • 36. Etanercept in the treatment of palmoplantar pustulosis.
    Bissonnette R; Poulin Y; Bolduc C; Maari C; Provost N; Syrotuik J; Poulin-Costello CM; Nigen S
    J Drugs Dermatol; 2008 Oct; 7(10):940-6. PubMed ID: 19112757
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Commentary on the European S3-guidelines on the systemic treatment of psoriasis.
    Giannetti A
    J Eur Acad Dermatol Venereol; 2010 Mar; 24(3):368; author reply 368-9. PubMed ID: 20070453
    [No Abstract]   [Full Text] [Related]  

  • 38. Effects of etanercept on urine neopterin levels in patients with psoriasis in a controlled, open-label study.
    Koc E; Tunca M; Akgul EO; Akar A; Kurt Y; Kurumlu Z; Erbil K; Kilic S
    J Dermatol; 2009 Apr; 36(4):191-6. PubMed ID: 19348656
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-tumour necrosis factor-alpha therapy increases body weight in patients with chronic plaque psoriasis: a retrospective cohort study.
    Gisondi P; Cotena C; Tessari G; Girolomoni G
    J Eur Acad Dermatol Venereol; 2008 Mar; 22(3):341-4. PubMed ID: 18005022
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Conversion to positive tuberculosis test during etanercept treatment of psoriasis.
    Sumner W; Feldman SR
    J Drugs Dermatol; 2007 Oct; 6(10):1048. PubMed ID: 17966185
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.